NRX Pharmaceuticals, Inc.
NRXP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001719406
No open-market purchases or sales by NRX Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $47.6M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in NRX Pharmaceuticals, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- −4 vs. Q4 2021
- Shares held
- 10.3M
- +7.67M (+295.7%) vs. Q4 2021
- Total value
- $25.1M
- +$12.7M (+102.8%) vs. Q4 2021
- New holders
- 8
- 12 more added
- Sold out
- 12
- 8 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NRXP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 47 | $47.6M |
| Q1 2026 | 33 | $13.2M |
| Q4 2025 | 28 | $14.2M |
| Q3 2025 | 24 | $13.0M |
| Q2 2025 | 25 | $9.76M |
| Q1 2025 | 22 | $4.60M |
| Q4 2024 | 25 | $2.31M |
| Q3 2024 | 18 | $1.21M |
| Q2 2024 | 19 | $1.29M |
| Q1 2024 | 31 | $1.76M |
| Q4 2023 | 30 | $1.84M |
| Q3 2023 | 34 | $964.7K |
| Q2 2023 | 32 | $4.78M |
| Q1 2023 | 30 | $2.07M |
| Q4 2022 | 33 | $3.44M |
| Q3 2022 | 30 | $3.04M |
| Q2 2022 | 37 | $2.18M |
| Q1 2022 | 34 | $25.1M |
| Q4 2021 | 38 | $12.4M |
| Q3 2021 | 23 | $16.2M |
| Q2 2021 | 18 | $18.9M |
| Q1 2021 | 1 | $4.00K |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding NRX Pharmaceuticals, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 6,259,781 | $15.3M | 0.44% | +6,259,781 | New |
| Vanguard Group Inc | 1,075,317 | $2.63M | 0.00% | −96,916−8.3% | Reduced |
| Sabby Management, LLC | 782,473 | $1.92M | 0.82% | +782,473 | New |
| CVI Holdings, LLC | 625,978 | $1.53M | 0.10% | +625,978 | New |
| BlackRock Inc. | 525,493 | $1.29M | 0.00% | +10,045+1.9% | Added |
| Geode Capital Management, LLC | 293,867 | $719.0K | 0.00% | +82,367+38.9% | Added |
| Renaissance Technologies LLC | 139,003 | $341.0K | 0.00% | +139,003 | New |
| State Street Corp | 114,240 | $280.0K | 0.00% | +103,940+1,009.1% | Added |
| Northern Trust Corp | 58,598 | $144.0K | 0.00% | +22,322+61.5% | Added |
| Morgan Stanley | 51,797 | $128.0K | 0.00% | −5,547−9.7% | Reduced |
| Owl Creek Asset Management, L.P. | 50,000 | $123.0K | 0.01% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 34,388 | $84.0K | 0.00% | −2,717−7.3% | Reduced |
| Group One Trading, L.P. | 33,888 | $83.0K | 0.00% | +27,629+441.4% | Added |
| Susquehanna International Group, LLP | 30,609 | $75.0K | 0.00% | −48,347−61.2% | Reduced |
| Goldman Sachs Group Inc | 21,294 | $52.0K | 0.00% | +1,675+8.5% | Added |
| Cubist Systematic Strategies, LLC | 20,541 | $50.0K | 0.00% | +8,768+74.5% | Added |
| United Asset Strategies, Inc. | 18,300 | $45.0K | 0.01% | +18,300 | New |
| Simplex Trading, LLC | 17,720 | $43.0K | 0.00% | +6,155+53.2% | Added |
| Citigroup Inc | 15,208 | $37.0K | 0.00% | +11,866+355.1% | Added |
| Ursa Fund Management, LLC | 15,000 | $37.0K | 0.03% | +15,000 | New |
| Charles Schwab Investment Management Inc | 12,000 | $30.0K | 0.00% | 00.0% | Unchanged |
| Davenport & Co LLC | 10,000 | $25.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 10,129 | $25.0K | 0.00% | +10,129 | New |
| Advisor Group Holdings, Inc. | 9,180 | $22.0K | 0.00% | −35,660−79.5% | Reduced |
| JPMorgan Chase & Co | 6,952 | $17.0K | 0.00% | +1,768+34.1% | Added |
| Penserra Capital Management LLC | 6,409 | $15.0K | 0.00% | +3,288+105.4% | Added |
| Tower Research Capital LLC (TRC) | 5,134 | $13.0K | 0.00% | +4,915+2,244.3% | Added |
| Wells Fargo & Company | 5,000 | $12.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,527 | $11.0K | 0.00% | −7,215−61.4% | Reduced |
| Cutler Group LP | 3,220 | $7.00K | 0.00% | −3,799−54.1% | Reduced |
| Exchange Traded Concepts, LLC | 1,894 | $5.00K | 0.00% | +1,894 | New |
| Bank of America Corp | 1,487 | $3.00K | 0.00% | −2,884−66.0% | Reduced |
| Larson Financial Group LLC | 218 | $1.00K | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 172 | $0 | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −61,583−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −53,732−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −29,496−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −28,100−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −25,326−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −25,210−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −13,257−100.0% | Sold out |
| Wealthcare Advisory Partners LLC | 0 | $0 | 0.00% | −13,000−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −11,567−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −2,499−100.0% | Sold out |
| Psagot Value Holdings Ltd. / (Israel) | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −1,700−100.0% | Sold out |